<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6</volume><submitter>Santiago-Cruz W</submitter><pubmed_abstract>CD38 is a transmembrane glycoprotein involved in NAD&lt;sup>+&lt;/sup> metabolism, calcium signaling, and immune cell activation. Its role in the inflammatory response has been studied extensively in innate immune cells; however, its contribution to the activation of memory T lymphocytes under inflammatory conditions is less understood. Additionally, recent studies have shown an age-related increase in the expression of the protein CD38 in various human and murine tissues. Moreover, CD8&lt;sup>+&lt;/sup> bystander T cells have been shown to contribute to inflammation during the aging process. Given the importance of its potential role in age-related pathologies, we examined the effect of CD38 on bystander activation of CD8&lt;sup>+&lt;/sup> memory T cells in aged mice following lipopolysaccharide challenge. CD38-deficient mice exhibited attenuated serum cytokine responses (IL-1β, IL-6, IFN-γ, and IL-10) and a distinct CD8&lt;sup>+&lt;/sup> T cell profile, characterized by a decrease in activated T cells. Wild-type mice displayed a significant expansion of CD69&lt;sup>+&lt;/sup>T&lt;sub>CM&lt;/sub> cells after LPS inoculation, an effect that was absent in CD38-deficient animals. LPS also promoted the expression of CD69 and CD38 in T&lt;sub>EM/EFF&lt;/sub> subsets. Thus, our findings reveal a CD38-dependent mechanism underlying bystander activation of memory CD8&lt;sup>+&lt;/sup> T cells in aging. Highlighting the potential contribution of CD38 to age-related diseases, such as autoimmunity, and in the face of inflammatory conditions in aged people.</pubmed_abstract><journal>Frontiers in aging</journal><pagination>1701685</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12757697</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CD38 promotes LPS-induced innate-like activation and proliferation of CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T lymphocytes in aged mice.</pubmed_title><pmcid>PMC12757697</pmcid><pubmed_authors>Perez-Lara JC</pubmed_authors><pubmed_authors>Garcia-Garcia F</pubmed_authors><pubmed_authors>Rodriguez-Alba JC</pubmed_authors><pubmed_authors>Espinosa E</pubmed_authors><pubmed_authors>Devarajan P</pubmed_authors><pubmed_authors>Santiago-Cruz W</pubmed_authors><pubmed_authors>Romero-Ramirez H</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD38 promotes LPS-induced innate-like activation and proliferation of CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T lymphocytes in aged mice.</name><description>CD38 is a transmembrane glycoprotein involved in NAD&lt;sup>+&lt;/sup> metabolism, calcium signaling, and immune cell activation. Its role in the inflammatory response has been studied extensively in innate immune cells; however, its contribution to the activation of memory T lymphocytes under inflammatory conditions is less understood. Additionally, recent studies have shown an age-related increase in the expression of the protein CD38 in various human and murine tissues. Moreover, CD8&lt;sup>+&lt;/sup> bystander T cells have been shown to contribute to inflammation during the aging process. Given the importance of its potential role in age-related pathologies, we examined the effect of CD38 on bystander activation of CD8&lt;sup>+&lt;/sup> memory T cells in aged mice following lipopolysaccharide challenge. CD38-deficient mice exhibited attenuated serum cytokine responses (IL-1β, IL-6, IFN-γ, and IL-10) and a distinct CD8&lt;sup>+&lt;/sup> T cell profile, characterized by a decrease in activated T cells. Wild-type mice displayed a significant expansion of CD69&lt;sup>+&lt;/sup>T&lt;sub>CM&lt;/sub> cells after LPS inoculation, an effect that was absent in CD38-deficient animals. LPS also promoted the expression of CD69 and CD38 in T&lt;sub>EM/EFF&lt;/sub> subsets. Thus, our findings reveal a CD38-dependent mechanism underlying bystander activation of memory CD8&lt;sup>+&lt;/sup> T cells in aging. Highlighting the potential contribution of CD38 to age-related diseases, such as autoimmunity, and in the face of inflammatory conditions in aged people.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-06T10:37:58.829Z</modification><creation>2026-05-29T03:12:08.391Z</creation></dates><accession>S-EPMC12757697</accession><cross_references><pubmed>41488275</pubmed><doi>10.3389/fragi.2025.1701685</doi></cross_references></HashMap>